Myocardial Infarction News and Research

RSS

Cardiovascular risks post-COVID-19 vaccination: Key findings

Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.

3 Oct 2024

Study highlights the role of genetic factors in COVID-19 thrombosis and inflammation

Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process of breaking blood clots, and heightened inflammatory responses.

3 Oct 2024

Ketogenic diet lowers mortality by 24% while maintaining heart health

Study confirms that adherence to a ketogenic diet reduces all-cause mortality risk by 24% without increasing cardiovascular mortality in a large US cohort. Findings support KD as a beneficial intervention for long-term health.

3 Oct 2024

Study uncovers hidden proteins fueling heart disease and stroke

Researchers identified key proteins linked to cardiovascular disease, highlighting new targets for drug development using genetic and observational analyses in UK and China biobanks.

26 Sep 2024

Older adults face higher CVD risk post-cancer treatment

Older adults treated for cancer face twice the risk of developing cardiovascular diseases compared to those without cancer. The highest risks are seen in patients with metastatic, hematologic, and lung cancers, especially after chemotherapy.

25 Sep 2024

Updated Nutri-Score system reveals stronger links between poor diet and cardiovascular disease risk

A large European study finds that consuming foods with lower nutritional quality, as graded by the updated Nutri-Score, increases the risk of cardiovascular diseases, particularly stroke and heart attack.

18 Sep 2024

New study links lower Nutri-score foods to increased cardiovascular risk

Cardiovascular diseases are the leading cause of mortality in Western Europe, accounting for 1/3 of deaths in 2019.

12 Sep 2024

Atrial fibrillation affects more Americans than previously estimated

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5% of the population, or 10.5 million U.S. adults, according to new estimates from UC San Francisco.

11 Sep 2024

Diligence associated with better cardiovascular outcomes in type 2 diabetes patients

People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research published in the open access journal BMJ Open Diabetes Research & Care.

10 Sep 2024

Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic

Semaglutide significantly reduces all-cause mortality in non-diabetic obese patients, particularly by lowering infection-related deaths during the COVID-19 pandemic. However, the study's findings should be interpreted with caution due to potential competing risks and unique pandemic circumstances.

5 Sep 2024

Key insights into cardiac metabolism dysfunction in the elderly

A new editorial was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 16 on August 19, 2024, entitled, "Cardiac metabolism in the elderly: effects and consequences."

4 Sep 2024

Alirocumab reduces dangerous coronary plaque and stabilizes high-risk lesions

Intensive LDL-C lowering with alirocumab significantly reduces high-risk coronary plaque burden, transforming unstable plaques into more stable phenotypes. This lesion-level analysis underscores the enhanced efficacy compared to vessel-level approaches.

4 Sep 2024

Complete revascularization proves effective for older STEMI patients in first 4 years

The benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Invasive strategy shows no benefit in cardiovascular death reduction for older NSTEMI patients

An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death or MI, although non-fatal MIs and subsequent revascularisation procedures were reduced, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Study finds higher heart attack risk days after cold exposure

Hospital admissions for heart attacks increase after exposure to lower air temperature and cold spells, according to a study published today in JACC, the flagship journal of the American College of Cardiology, and presented at the European Society of Cardiology (ESC) Congress 2024.

1 Sep 2024

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Rising resting heart rate over the years linked to shorter lifespan, study show

Study finds that increases in resting heart rate over time significantly raise mortality risk, underscoring heart rate as a key factor in lifespan determination.

1 Sep 2024

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.

1 Sep 2024

Evening versus morning dosing of antihypertensive medications provides no added benefits

In two trials, one in frail elderly patients, evening administration of blood pressure (BP)-lowering medications had no clinical benefits over morning administration, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Timing of blood pressure medication administration does not affect outcomes

Evening administration of blood pressure (BP)-lowering medications did not reduce the risk of cardiovascular events or death compared with morning administration, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Myocardial Infarction News and Research

Cardiovascular risks post-COVID-19 vaccination: Key findings

Study highlights the role of genetic factors in COVID-19 thrombosis and inflammation

Ketogenic diet lowers mortality by 24% while maintaining heart health

Study uncovers hidden proteins fueling heart disease and stroke

Older adults face higher CVD risk post-cancer treatment

Updated Nutri-Score system reveals stronger links between poor diet and cardiovascular disease risk

New study links lower Nutri-score foods to increased cardiovascular risk

Atrial fibrillation affects more Americans than previously estimated

Diligence associated with better cardiovascular outcomes in type 2 diabetes patients

Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic

Key insights into cardiac metabolism dysfunction in the elderly

Alirocumab reduces dangerous coronary plaque and stabilizes high-risk lesions

Complete revascularization proves effective for older STEMI patients in first 4 years

Invasive strategy shows no benefit in cardiovascular death reduction for older NSTEMI patients

Study finds higher heart attack risk days after cold exposure

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Rising resting heart rate over the years linked to shorter lifespan, study show

New study confirms safety of SGLT2 inhibitors after acute myocardial infarction

Evening versus morning dosing of antihypertensive medications provides no added benefits

Timing of blood pressure medication administration does not affect outcomes

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News